A Phase I Dose Escalation Study of Pemetrexed in Patients With Advanced Head and Neck Squamous Cell Cancer.
Phase of Trial: Phase I
Latest Information Update: 22 Sep 2011
At a glance
- Drugs Dexamethasone; Pemetrexed
- Indications Head and neck cancer
- Focus Adverse reactions
- 22 Sep 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Apr 2011 Planned end date changed from 1 Sep 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 27 Sep 2010 Planned end date changed from 1 Sep 2009 to 1 Sep 2011 as reported in ClinicalTrials.gov record.